Effects of retinoic acid and fenretinide on the c-erbB 2 expression, growth and cisplatin sensitivity of breast cancer cells
1998
Effects of Retinoic Acid and Fenretinide on Breast Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): ThW Grunt, E Dittrich, M Offterdinger, SM Schneider, Ch Dittrich, H Huber
Primary Institution: University of Vienna
Hypothesis
How do retinoic acid and fenretinide affect c-erbB-2 expression and sensitivity to cisplatin in breast cancer cells?
Conclusion
Both retinoids down-regulate c-erbB-2 expression and enhance the sensitivity of breast cancer cells to cisplatin.
Supporting Evidence
- Retinoids down-regulate c-erbB-2 protein and mRNA in breast cancer cells.
- ATRA induces differentiation in SK-BR-3 cells.
- 4-HPR causes apoptosis in breast cancer cells.
- Combinations of retinoids with cisplatin enhance growth inhibition.
- Retinoid conditioning is essential for improved antiproliferative effects.
Takeaway
This study shows that two drugs, retinoic acid and fenretinide, can help make breast cancer cells more sensitive to a chemotherapy drug called cisplatin.
Methodology
The study used ELISA, Western blotting, and Northern blotting to analyze the effects of retinoids on breast cancer cell lines.
Want to read the original?
Access the complete publication on the publisher's website